RecruitingNot ApplicableNCT07132099

Randomized Suicide Prevention Trial Using ASSIP and ACT in Suicide Attempters

RCT Comparing ASSIP and ACT on Mental Pain and Suicidal Ideation in Individuals With Suicide Attempts


Sponsor

Ardakan University

Enrollment

60 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized controlled trial that aims to compare the effectiveness of two psychological treatment approaches: the Attempted Suicide Short Intervention Program (ASSIP) and Acceptance and Commitment Therapy (ACT). The study seeks to determine which of these two methods is more effective in reducing suicidal ideation and mental pain in individuals who have recently attempted suicide. In this study, 60 participants with a history of suicide attempts will be randomly assigned to three groups. One group will receive ASSIP in addition to treatment as usual (TAU), the second group will receive ACT alongside TAU, and the third group will be a control group receiving TAU only. The results will be assessed using the Beck Scale for Suicide Ideation (BSSI) and the Orbach \& Mikulincer Mental Pain Scale (OMMP) at three stages: pre-test, post-test, and follow-up. The ultimate goal of this research is to provide valuable insights into the comparative effectiveness of ASSIP and ACT interventions for suicide attempters and to contribute to evidence-based suicide prevention strategies. The findings are expected to inform clinical practice and guide future research in this field.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Being 18 years of age or older
  • Having the ability to read and write
  • Providing informed consent to participate in the study
  • Having at least one suicide attempt in the past 4 months

Exclusion Criteria4

  • Having a severe psychiatric or physical illness that interferes with the treatment process
  • Receiving concurrent structured psychological interventions (other than TAU) that may interfere with the study's treatment process.
  • Lack of informed consent to participate in the study
  • Substance abuse based on DSM-5 criteria

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAttempted Suicide Short Intervention Program (ASSIP)

This is a brief, structured, patient-centered therapy consisting of three to four face-to-face sessions. Each session typically lasts between 60 to 90 minutes. A fourth session may be added if clinically necessary.

BEHAVIORALAcceptance and Commitment Therapy (ACT)

This intervention uses the "ACT for Life" protocol, which is designed to maximize recovery after suicidal crises. It consists of three components delivered over three to six individual sessions. The average number of sessions is four to five, with each session lasting approximately 60 minutes.

OTHERTreatment as Usual (TAU)

Treatment as usual (TAU) is not a structured intervention within this study. It may include standard outpatient or inpatient services, pharmacotherapy, or no structured treatment, depending on individual circumstances.


Locations(1)

The Imam Hossein District Health Center

Eslamshahr, Tehran Province, Iran

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07132099


Related Trials